Journal of Korean Medical Science · 2016 · 18 citations · 10 references
MedicineRespiratory TherapyClinical Decision SupportSurvival AnalysisVentilator ManagementAcute Respiratory Distress SyndromeAcute Respiratory FailureExtracorporeal Life SupportExtracorporeal Membrane OxygenationRespiratory Distress SyndromeSurvival OutcomesAcute Respiratory Distress Syndrome AssessmentMortality PredictionOutcome PredictionOutcome Scoring SystemsOverall MortalityPredictive PerformancePredictors Of Successful WeaningRespiratory Failure Prognosis
Recently, several prognostic scoring systems for patients with severe acute respiratory distress syndrome (ARDS) requiring extracorporeal membrane oxygenation (ECMO) have been published. The aim of this study was to validate the established scoring systems for outcome prediction in Korean patients. We retrospectively reviewed the data of 50 patients on ECMO therapy in our center from 2012 to 2014. A calculation of outcome prediction scoring tools was performed and the comparison across various models was conducted. In our study, the overall hospital survival was 46% and successful weaning rate was 58%. The Predicting Death for Severe ARDS on V-V ECMO (PRESERVE) score showed good discrimination of mortality prediction for patients on ECMO with AUC of 0.80 (95% CI 0.66-0.90). The respiratory extracorporeal membrane oxygenation survival prediction (RESP) score and simplified acute physiology score (SAPS) II score also showed fair prediction ability with AUC of 0.79 (95% CI 0.65-0.89) and AUC of 0.78 (95% CI 0.64-0.88), respectively. However, the ECMOnet score failed to predict mortality with AUC of 0.51 (95% CI 0.37-0.66). When evaluating the predictive accuracy according to optimal cut-off point of each scoring system, RESP score had a best specificity of 91.3% and 66.7% of sensitivity, respectively. This study supports the clinical usefulness of the prognostic scoring tools for severe ARDS with ECMO therapy when applying to the Korean patients receiving ECMO.
10
Giles J. Peek, Miranda Mugford, Ravindranath Tiruvoipati et al. · The Lancet · 2009 · 3.4K citations
Medicine, Respiratory Therapy, Cost-effectiveness Analysis +11
Matthieu Schmidt, Michael Bailey, Jayne Sheldrake et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 855 citations
Medicine, Respiratory Therapy, Clinical Decision Support +16
Matthieu Schmidt, Élie Zogheib, Hadrien Rozé et al. · Intensive Care Medicine · 2013 · 583 citations · Full text
Tài Pham, Alain Combes, Hadrien Rozé et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 500 citations
Medicine, Respiratory Therapy, Critical Care Respiratory Therapy +16